Active Ingredient: MIRDAMETINIB
Proprietary Name: GOMEKLI
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 1MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N219379
Product Number: 001
Approval Date: Feb 11, 2025
Applicant Holder Full Name: SPRINGWORKS THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
